cnn.com
The complex connection between period pain and depression is better understood thanks to a new study published in Briefings in Bioinformatics. Researchers have identified specific genes associated with depression that may increase the likelihood of menstrual pain by 51%. These findings shed light on a significant genetic link between the two conditions and could influence future approaches to diagnosis and treatment.
Menstrual pain, also known as dysmenorrhea, affects up to 90% of menstruating individuals. While often attributed to uterine contractions or prostaglandin overactivity, its connection with depression has remained unclear. Traditionally, it was believed that intense pain triggered depressive symptoms. However, the study proposes an alternative perspective: that depression may drive the experience of period pain due to genetic factors.
To explore this relationship, researchers used Mendelian randomization, a method that leverages genetic data to examine cause-and-effect without direct experiments. By analyzing data from 600,000 participants of European descent and 8,000 East Asian participants, the study identified biological pathways and proteins linking depression to menstrual pain. Notably, no evidence was found to suggest that period pain causes depression.
The study also highlighted how sleeplessness, a common symptom of depression, may exacerbate period pain. However, the researchers emphasized that the interplay of genetic and environmental factors remains complex and warrants further exploration.
Dr. John Moraros, the study’s lead author, described the findings as a step toward integrating mental and reproductive health care. “Our collective goal is to critically investigate these issues and improve care for women by uncovering these complex connections and finding better ways to address them,” he said.
While the study emphasizes genetics, experts like Dr. Anne-Marie Amies Oelschlager, a professor of obstetrics and gynecology at the University of Washington, caution against oversimplifying the results. “Many people who have depression or other mood disorders experience pain more acutely. That increased intensity is due to how the brain interprets and experiences pain signals, and to depression limiting one’s ability to cope with pain,” she said. This means genetic predisposition alone may not fully explain the connection. Additionally, other factors like early menopause, endometriosis, and early menarche are known to influence depression and dysmenorrhea.
“Where I think the paper’s falling short is that because there’s a strong genetic connection, you attributed that as a causal relationship, and I think it’s still a stretch,” said Dr. Claudio Soares, professor in the department of psychiatry at Queen’s University School of Medicine and president of the Menopause Society.
Experts also noted the Mendelian randomization method assumes no environmental influences on depression, period pain, or genetics, which doesn’t reflect the multifactorial nature of these conditions
The findings suggest that mental health evaluations could play an important role in managing menstrual pain. For individuals experiencing severe dysmenorrhea that disrupts daily life, a comprehensive approach addressing both mood disorders and underlying gynecological conditions—such as fibroids, infections, or ovarian cysts—could lead to better outcomes.
Lifestyle changes that benefit both conditions include exercise, stress reduction, improved sleep, and dietary adjustments. “Integrated care can lead to more personalized treatments and help reduce the stigma surrounding mental and reproductive health issues,” Moraros said. If non-pharmacological approaches are insufficient, medications like prostaglandin inhibitors remain effective options.
This research contributes to an ongoing conversation about the intersection of mental and reproductive health, highlighting the need for holistic care models. While the study advances our understanding of the genetic overlap between depression and period pain, experts agree that further research is needed to clarify the roles of environmental factors and other individual differences.
By addressing both depression and dysmenorrhea together, health care providers can develop tailored strategies to improve the quality of life for patients affected by these conditions.